Obesity Linked to Ovarian Cancer
Excess estrogen may contribute to malignancy, study suggests. Obese postmenopausal women who have never used hormone replacement therapy may face an increased risk of ovarian cancer, compared to normal-weight women, a new study suggests.
Interestingly, obese women who have used hormone replacement therapy (HRT) for symptoms of menopause may not face increased risk for this type of malignancy.
The study findings are published in the Feb.
More ...
More articles below:
Dubious Drugs, Tainted Foods Top 2008's Health Stories
Gene Mutation Tied to Inherited Fatal Lung Disease
Vitamins Fail to Prevent Cancer
View All Related Articles
DON'T HAVE Rx COVERAGE?Click Here to print out your FREE OPTIMIZERx Card and instantly begin savings on your next prescriptions!



